Desvenlafaxine in the treatment of major depression: an updated overview
TR Norman, JS Olver - Expert opinion on pharmacotherapy, 2021 - Taylor & Francis
Introduction: Major depressive disorder (MDD) remains one of the most prevalent mental
health conditions. It is a chronic, relapsing condition and despite multiple treatment options …
health conditions. It is a chronic, relapsing condition and despite multiple treatment options …
A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive …
W Mi, X Di, Y Wang, H Li, X Xu, L Li, H Wang… - Translational …, 2023 - nature.com
Major depressive disorder (MDD) is the most prevalent form of depression and is becoming
a great challenge for public health and medical practice. Although first-line antidepressants …
a great challenge for public health and medical practice. Although first-line antidepressants …
Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper
Introduction Major depressive disorder (MDD) is a common severe mental disorder,
requiring a tailored and integrated treatment. Several approaches are available including …
requiring a tailored and integrated treatment. Several approaches are available including …
The analysis of network structure among the depressive symptoms in a clinical sample of children and adolescents
The symptoms of depressive disorder in children and adolescents vary widely and have
complex interconnections with each other. This study aimed to identify the network structures …
complex interconnections with each other. This study aimed to identify the network structures …
Anxiolytic effect of carvedilol in chronic unpredictable stress model
CNS de Sousa, I da Silva Medeiros… - Oxidative Medicine …, 2022 - Wiley Online Library
Anxiety disorders are the most prevalent psychiatric disorders being also a comorbid state of
other diseases. We aimed to evaluate the anxiolytic‐like effects of carvedilol (CVD), a drug …
other diseases. We aimed to evaluate the anxiolytic‐like effects of carvedilol (CVD), a drug …
Symptom clusters in adolescent depression and differential responses of clusters to pharmacologic treatment
Objective Symptoms of depression in adolescents are widely variable, but they are often
interactive and clustered. The analysis of interactions and clusters among individual …
interactive and clustered. The analysis of interactions and clusters among individual …
[HTML][HTML] Clustering patients by depression symptoms to predict venlafaxine ER antidepressant efficacy: Individual patient data analysis
M Kato, Y Asami, DB Wajsbrot, X Wang… - Journal of Psychiatric …, 2020 - Elsevier
Objective To identify clusters of patients with major depressive disorder (MDD) based on the
baseline 17-item Hamilton Rating Scale for Depression (HAM-D 17) items and to evaluate …
baseline 17-item Hamilton Rating Scale for Depression (HAM-D 17) items and to evaluate …
[HTML][HTML] Efficacy of adjunctive brexpiprazole on symptom clusters of major depressive disorder: A post hoc analysis of four clinical studies
MA Katzman, F Therrien, EM MacKenzie… - Journal of Affective …, 2022 - Elsevier
Background Major depressive disorder (MDD) is a clinically heterogenous condition and its
treatment should be individualized according to the presence of particular symptom clusters …
treatment should be individualized according to the presence of particular symptom clusters …
Network Structure and Clustering Analysis Relating to Individual Symptoms of Problematic Internet Use in a Community Adolescent Population
HS Jeong, HMS Kim, KM Kim - European Addiction Research, 2024 - karger.com
Introduction: Problematic internet use (PIU) is a psychopathology that includes multiple
symptoms and psychological constructs. Because no studies have considered both network …
symptoms and psychological constructs. Because no studies have considered both network …
Prescribing Antidepressant Medication
DS Kroll - Caring for Patients with Depression in Primary Care, 2022 - Springer
First-line antidepressant medications include selective serotonin reuptake inhibitors (SSRIs),
serotonin-norepinephrine reuptake inhibitors (SNRIs), bupropion, and mirtazapine. All of …
serotonin-norepinephrine reuptake inhibitors (SNRIs), bupropion, and mirtazapine. All of …